Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Drug and Alcohol Dependence
|
September 30, 2022
Assessment of dependence potential and abuse liability of Δ<sup>8</sup>-tetrahydrocannabinol in mice
S O Vanegas, A M Reck, C E Rodriguez, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor
J W Huffman, S Yu, V Showalter, et al.
Neuropharmacology
|
January 1, 1996
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol
J L Wiley, D R Compton, P M Gordon, et al.
British Journal of Pharmacology
|
July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase
L Thors, J J Burston, B J Alter, et al.
Psychopharmacology
|
April 25, 2012
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice
K M Tobey, D M Walentiny, J L Wiley, et al.
Harper'S
|
November 1, 1992
She's come for an abortion: what do you say?
K Luker, W F Buckley, L Barry, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays
T W Grim, A J Morales, M M Gonek, et al.
British Journal of Pharmacology
|
July 16, 2013
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
B M Ignatowska-Jankowska, S Ghosh, M S Crowe, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Drug and Alcohol Dependence
|
September 30, 2022
Assessment of dependence potential and abuse liability of Δ<sup>8</sup>-tetrahydrocannabinol in mice
S O Vanegas, A M Reck, C E Rodriguez, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor
J W Huffman, S Yu, V Showalter, et al.
Neuropharmacology
|
January 1, 1996
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol
J L Wiley, D R Compton, P M Gordon, et al.
British Journal of Pharmacology
|
July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase
L Thors, J J Burston, B J Alter, et al.
Psychopharmacology
|
April 25, 2012
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice
K M Tobey, D M Walentiny, J L Wiley, et al.
Harper'S
|
November 1, 1992
She's come for an abortion: what do you say?
K Luker, W F Buckley, L Barry, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays
T W Grim, A J Morales, M M Gonek, et al.
British Journal of Pharmacology
|
July 16, 2013
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
B M Ignatowska-Jankowska, S Ghosh, M S Crowe, et al.
Page
of 7